The secretin-autism question settled by a controlled trial: no benefit

Research 95/100Rated 95/100Source typePeer-reviewed studyIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
December 9, 1999↗ source

After thousands of families sought secretin injections for autism following anecdotal TV reports, a double-blind NEJM trial (Sandler et al., 9 December 1999) tested a single dose of synthetic human secretin in 60 children and found no benefit over placebo on any behavioral or language measure - a landmark negative result for evidence over anecdote.

Related peptides

We summarize, we don't invent — every detail here traces to a real, linked source, and the badge reflects how trustworthy that source is. Read the original and decide for yourself.

Free: The Peptide Stack Cheat-Sheet

The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.

No spam. Unsubscribe anytime.